Vivolux applies the solid scientific competence found in the company network to the development of new and innovative applications for use in cancer therapy. Our research and development projects are supported by advanced culture systems for drug screening and lead optimization.

Research and the manufacturing of internal compounds take place in-house at Vivolux. The assessment and development of the optimal approach to external leads is a collaborative process between the company and its partners. This guarantees the highest possible level of expertise and acts as an incentive at each stage in the product development process. Once in the clinical phase the projects are divided into separate companies that are financed within the Vivolux network of financial and commercial collaborators.

Vivolux AB, Uppsala Science Park, Hus Oscar II, SE 751 83 Uppsala, Sweden. Phone +46 708 583470